Cargando…
The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials
(1) Background: The effects of resveratrol on blood lipids are controversial. Whether there is a dose-response of the lipid profile upon resveratrol supplementation is unknown. (2) Methods: This dose-response meta-analysis of randomized controlled trials (RCTs) was performed to explore the effects o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506025/ https://www.ncbi.nlm.nih.gov/pubmed/36145131 http://dx.doi.org/10.3390/nu14183755 |
_version_ | 1784796619818926080 |
---|---|
author | Cao, Xinyi Liao, Wang Xia, Hui Wang, Shaokang Sun, Guiju |
author_facet | Cao, Xinyi Liao, Wang Xia, Hui Wang, Shaokang Sun, Guiju |
author_sort | Cao, Xinyi |
collection | PubMed |
description | (1) Background: The effects of resveratrol on blood lipids are controversial. Whether there is a dose-response of the lipid profile upon resveratrol supplementation is unknown. (2) Methods: This dose-response meta-analysis of randomized controlled trials (RCTs) was performed to explore the effects of resveratrol supplementation on lipid profile. A systematical and comprehensive search of several databases was conducted by 30 June 2022. (3) Results: The results indicated that the intake of resveratrol could significantly decrease the total cholesterol (TC) (mean difference = −10.28; 95%CI: −13.79, −6.76, p < 0.001), triglyceride (TG) (Mean difference = −856; 95%CI: −12.37, −4.75, p < 0.001) and low-density lipoprotein cholesterol (LDL-C) (mean difference = −5.69; 95%CI: −11.07, −0.31, p = 0.038) level, but did not alter the level of high-density lipoprotein cholesterol (HDL-C). In the non-linear dose–response analysis, we observed a significant effect of the supplementation dosage on the level of LDL-C (p-nonlinearity = 0.002). Results from the sub-group analysis showed that the reduction of LDL-C was more significant in the trials with a duration of ≥12 weeks and in subjects with type 2 diabetes mellitus. (4) Conclusion: Findings from this study suggest that resveratrol may be beneficial to reduce TC, TG, and LDL-C levels in the blood. The dosage of the resveratrol intervention is an essential factor that affects the level of LDL-C. |
format | Online Article Text |
id | pubmed-9506025 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95060252022-09-24 The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials Cao, Xinyi Liao, Wang Xia, Hui Wang, Shaokang Sun, Guiju Nutrients Review (1) Background: The effects of resveratrol on blood lipids are controversial. Whether there is a dose-response of the lipid profile upon resveratrol supplementation is unknown. (2) Methods: This dose-response meta-analysis of randomized controlled trials (RCTs) was performed to explore the effects of resveratrol supplementation on lipid profile. A systematical and comprehensive search of several databases was conducted by 30 June 2022. (3) Results: The results indicated that the intake of resveratrol could significantly decrease the total cholesterol (TC) (mean difference = −10.28; 95%CI: −13.79, −6.76, p < 0.001), triglyceride (TG) (Mean difference = −856; 95%CI: −12.37, −4.75, p < 0.001) and low-density lipoprotein cholesterol (LDL-C) (mean difference = −5.69; 95%CI: −11.07, −0.31, p = 0.038) level, but did not alter the level of high-density lipoprotein cholesterol (HDL-C). In the non-linear dose–response analysis, we observed a significant effect of the supplementation dosage on the level of LDL-C (p-nonlinearity = 0.002). Results from the sub-group analysis showed that the reduction of LDL-C was more significant in the trials with a duration of ≥12 weeks and in subjects with type 2 diabetes mellitus. (4) Conclusion: Findings from this study suggest that resveratrol may be beneficial to reduce TC, TG, and LDL-C levels in the blood. The dosage of the resveratrol intervention is an essential factor that affects the level of LDL-C. MDPI 2022-09-11 /pmc/articles/PMC9506025/ /pubmed/36145131 http://dx.doi.org/10.3390/nu14183755 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cao, Xinyi Liao, Wang Xia, Hui Wang, Shaokang Sun, Guiju The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials |
title | The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials |
title_full | The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials |
title_fullStr | The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed | The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials |
title_short | The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials |
title_sort | effect of resveratrol on blood lipid profile: a dose-response meta-analysis of randomized controlled trials |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506025/ https://www.ncbi.nlm.nih.gov/pubmed/36145131 http://dx.doi.org/10.3390/nu14183755 |
work_keys_str_mv | AT caoxinyi theeffectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT liaowang theeffectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT xiahui theeffectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT wangshaokang theeffectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT sunguiju theeffectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT caoxinyi effectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT liaowang effectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT xiahui effectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT wangshaokang effectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials AT sunguiju effectofresveratrolonbloodlipidprofileadoseresponsemetaanalysisofrandomizedcontrolledtrials |